ATE483797T1 - Harnsäureoxidase - Google Patents

Harnsäureoxidase

Info

Publication number
ATE483797T1
ATE483797T1 AT99938996T AT99938996T ATE483797T1 AT E483797 T1 ATE483797 T1 AT E483797T1 AT 99938996 T AT99938996 T AT 99938996T AT 99938996 T AT99938996 T AT 99938996T AT E483797 T1 ATE483797 T1 AT E483797T1
Authority
AT
Austria
Prior art keywords
proteins
uric acid
uricase
acid oxidase
relates
Prior art date
Application number
AT99938996T
Other languages
English (en)
Inventor
Michael Hershfield
Susan Kelly
Original Assignee
Univ Duke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Duke filed Critical Univ Duke
Application granted granted Critical
Publication of ATE483797T1 publication Critical patent/ATE483797T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0044—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on other nitrogen compounds as donors (1.7)
    • C12N9/0046—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on other nitrogen compounds as donors (1.7) with oxygen as acceptor (1.7.3)
    • C12N9/0048—Uricase (1.7.3.3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0044—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on other nitrogen compounds as donors (1.7)
    • C12N9/0046—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on other nitrogen compounds as donors (1.7) with oxygen as acceptor (1.7.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y107/00—Oxidoreductases acting on other nitrogenous compounds as donors (1.7)
    • C12Y107/03—Oxidoreductases acting on other nitrogenous compounds as donors (1.7) with oxygen as acceptor (1.7.3)
    • C12Y107/03003—Factor-independent urate hydroxylase (1.7.3.3), i.e. uricase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Veterinary Medicine (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT99938996T 1998-08-06 1999-08-05 Harnsäureoxidase ATE483797T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9548998P 1998-08-06 1998-08-06
PCT/US1999/017678 WO2000008196A2 (en) 1998-08-06 1999-08-05 Urate oxidase

Publications (1)

Publication Number Publication Date
ATE483797T1 true ATE483797T1 (de) 2010-10-15

Family

ID=22252247

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99938996T ATE483797T1 (de) 1998-08-06 1999-08-05 Harnsäureoxidase

Country Status (23)

Country Link
US (1) US7056713B1 (de)
EP (2) EP2277998B1 (de)
JP (3) JP2002524053A (de)
KR (1) KR100841634B1 (de)
CN (2) CN101280293B (de)
AT (1) ATE483797T1 (de)
AU (1) AU766421B2 (de)
BR (1) BRPI9913360B8 (de)
CA (1) CA2337967C (de)
CY (1) CY1111001T1 (de)
CZ (1) CZ304223B6 (de)
DE (1) DE69942834D1 (de)
DK (1) DK1100880T3 (de)
ES (1) ES2352451T3 (de)
HK (3) HK1037214A1 (de)
HU (1) HU229774B1 (de)
IL (3) IL141221A0 (de)
NZ (1) NZ509633A (de)
PL (1) PL207369B1 (de)
PT (1) PT1100880E (de)
RU (1) RU2290439C2 (de)
WO (1) WO2000008196A2 (de)
ZA (1) ZA200100974B (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100488848B1 (ko) * 1998-08-06 2005-05-11 듀크 유니버서티 피이지-유레이트 옥시데이즈 접합체 및 그의 이용
US20060188971A1 (en) * 1998-08-06 2006-08-24 Duke University Urate oxidase
PT1588716E (pt) 1998-08-06 2011-05-25 Mountain View Pharmaceuticals Conjugados de peg-urato oxidase e sua utiliza??o
US6783965B1 (en) 2000-02-10 2004-08-31 Mountain View Pharmaceuticals, Inc. Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
CN101280293B (zh) * 1998-08-06 2013-09-11 杜克大学 尿酸氧化酶
CN100371439C (zh) * 2003-04-07 2008-02-27 北京双鹭药业股份有限公司 一种重组假丝酵母尿酸氧化酶的制备方法
CN100334207C (zh) * 2004-04-27 2007-08-29 杭州北斗生物技术有限公司 一种黄曲霉尿酸氧化酶的制备方法
US7811800B2 (en) * 2005-04-11 2010-10-12 Savient Pharmaceuticals, Inc. Variant form of urate oxidase and use thereof
AU2011257764B2 (en) * 2005-04-11 2012-04-05 Horizon Therapeutics Usa, Inc. A variant form of urate oxidase and use thereof
LT3321359T (lt) * 2005-04-11 2021-05-10 Horizon Pharma Rheumatology Llc Urato oksidazės variantinės formos ir jų panaudojimas
US8148123B2 (en) 2005-04-11 2012-04-03 Savient Pharmaceuticals, Inc. Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
HU230758B1 (hu) * 2006-04-12 2018-03-28 Crealta Pharmaceuticals LLC 100% Fehérjék tisztítása kationos felületaktív anyaggal
CN101402688B (zh) * 2008-11-18 2011-04-20 中国人民解放军军事医学科学院生物工程研究所 一种融合蛋白及其编码基因与应用
MX2011009586A (es) 2009-03-24 2012-01-12 Meito Sangyo Kk Proteasa coagulante de leche de tipo mejorado derivada de microorganismo.
RU2535038C2 (ru) 2009-06-25 2014-12-10 Криэлта Фармасьютикалз ЭлЭлСи Способы и наборы для прогнозирования риска инфузионных реакций и опосредованной антителами потери ответа при терапии пэгилированной уриказой с помощью мониторинга содержания мочевой кислоты в сыворотке крови
CN102051348B (zh) 2009-10-27 2012-10-03 重庆富进生物医药有限公司 人源化重组尿酸酶及其突变体
RU2460793C2 (ru) 2010-01-15 2012-09-10 Закрытое акционерное общество "Научно-исследовательский институт "Аджиномото-Генетика" (ЗАО АГРИ) Способ получения l-аминокислот с использованием бактерий семейства enterobacteriaceae
US8940861B2 (en) 2010-04-08 2015-01-27 Georgia Tech Research Corporation Variants of ancestral uricases and uses thereof
CN102634492B (zh) 2011-02-14 2015-06-10 重庆富进生物医药有限公司 聚乙二醇化犬源尿酸氧化酶类似物及其制备方法和应用
CN102757945B (zh) * 2011-04-28 2015-03-18 杭州俊丰生物工程有限公司 人尿酸氧化酶蛋白及其制备方法和其聚乙二醇结合物
CN102260653B (zh) * 2011-06-30 2013-04-03 荣俊 一种peg化重组猪-人尿酸氧化酶融合蛋白的制备及应用方法
EP2986720B1 (de) * 2013-04-17 2017-09-06 Council of Scientific & Industrial Research Uricase mutanten
CN103834623B (zh) * 2014-02-11 2017-11-07 中国药科大学 具有催化活性的人源尿酸氧化酶
CN104388467A (zh) * 2014-10-27 2015-03-04 李长贵 一种构建自发性高尿酸血症小鼠模型的方法及其用途
CN107614007B (zh) 2015-05-15 2022-03-25 免疫医疗有限责任公司 改进的尿酸酶序列和治疗方法
CN106554948B (zh) 2015-09-29 2019-06-25 上海生物制品研究所有限责任公司 突变型尿酸酶、peg修饰的突变型尿酸酶及其应用
CN108103079B (zh) * 2017-06-20 2021-07-13 北京锦篮基因科技有限公司 一种高尿酸血症的基因治疗药物
CN109554376B (zh) * 2018-11-13 2022-03-22 广西大学 一种碱性尿酸氧化酶及其在检测试剂盒和降低食品中尿酸的应用
CN111088268B (zh) * 2019-03-05 2022-08-02 北京锦篮基因科技有限公司 一种高尿酸血症的基因治疗药物
EP3967754A4 (de) 2019-05-10 2023-07-26 Peg-Bio Biopharm Co., Ltd. (Chongqing) Polyethylenglycolmodifizierte uratoxidase
CN112646790A (zh) * 2019-10-11 2021-04-13 上海君实生物医药科技股份有限公司 改进的尿酸酶及其用于治疗高尿酸血症的方法
CN111920942A (zh) * 2020-08-24 2020-11-13 深圳前海鹰岗生物科技有限公司 一种用于快速溶解痛风石的聚合物微针及制备方法和应用
CN114438048A (zh) 2020-11-05 2022-05-06 重庆派金生物科技有限公司 尿酸氧化酶制剂及其应用
CN114438047A (zh) 2020-11-05 2022-05-06 重庆派金生物科技有限公司 制备聚乙二醇修饰的尿酸氧化酶的方法
CN112852772A (zh) * 2021-01-19 2021-05-28 中国科学院过程工程研究所 一种基于分子内交联和聚乙二醇修饰的尿酸氧化酶及其制备方法
CN112662640A (zh) * 2021-01-28 2021-04-16 中国药科大学 一种具有催化活性的尿酸氧化酶
CN113244412B (zh) * 2021-06-25 2021-10-26 深圳市瑞吉生物科技有限公司 一种基于mRNA剂型的治疗高尿酸血症或痛风的药物及其制备方法
AU2022340814A1 (en) * 2021-09-01 2024-02-15 Ginkgo Bioworks, Inc. Recombinant cells for treating diseases associated with uric acid and methods of use thereof

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE279486C (de)
US3613231A (en) 1969-07-25 1971-10-19 Paul F Pugh Method for manufacturing high voltage cable systems
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
DE3126759A1 (de) 1981-07-07 1983-01-27 Boehringer Mannheim Gmbh, 6800 Mannheim Loesliche leber-uricase, verfahren zu ihrer herstellung und verwendung
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4917888A (en) * 1985-06-26 1990-04-17 Cetus Corporation Solubilization of immunotoxins for pharmaceutical compositions using polymer conjugation
US4766106A (en) 1985-06-26 1988-08-23 Cetus Corporation Solubilization of proteins for pharmaceutical compositions using polymer conjugation
US4847325A (en) 1988-01-20 1989-07-11 Cetus Corporation Conjugation of polymer to colony stimulating factor-1
US5075216A (en) 1988-09-23 1991-12-24 Cetus Corporation Methods for dna sequencing with thermus aquaticus dna polymerase
US5349052A (en) 1988-10-20 1994-09-20 Royal Free Hospital School Of Medicine Process for fractionating polyethylene glycol (PEG)-protein adducts and an adduct for PEG and granulocyte-macrophage colony stimulating factor
US5324844A (en) 1989-04-19 1994-06-28 Enzon, Inc. Active carbonates of polyalkylene oxides for modification of polypeptides
US5382518A (en) 1989-07-13 1995-01-17 Sanofi Urate oxidase activity protein, recombinant gene coding therefor, expression vector, micro-organisms and transformed cells
US5286637A (en) 1989-08-07 1994-02-15 Debiopharm, S.A. Biologically active drug polymer derivatives and method for preparing same
US5653974A (en) 1990-10-18 1997-08-05 Board Of Regents,The University Of Texas System Preparation and characterization of liposomal formulations of tumor necrosis factor
WO1994019007A1 (en) 1993-02-16 1994-09-01 Enzon, Inc. Ribosome inactivating protein compositions having reduced antigenicity
AU7113594A (en) 1993-06-21 1995-01-17 Enzon, Inc. Site specific synthesis of conjugated peptides
US5919455A (en) 1993-10-27 1999-07-06 Enzon, Inc. Non-antigenic branched polymer conjugates
US5643575A (en) 1993-10-27 1997-07-01 Enzon, Inc. Non-antigenic branched polymer conjugates
EP0796324A1 (de) 1994-12-07 1997-09-24 Novo Nordisk A/S Polypeptide mit verminderter allergener wirkung
JPH09154581A (ja) 1995-12-05 1997-06-17 Asahi Chem Ind Co Ltd ウリカーゼを生産する実質上純粋な微生物
JP2001511162A (ja) 1997-02-06 2001-08-07 ノボ ノルディスク アクティーゼルスカブ 付加され、そして／又は除去された付着基を有するポリペプチド−ポリマー結合体
KR100488848B1 (ko) 1998-08-06 2005-05-11 듀크 유니버서티 피이지-유레이트 옥시데이즈 접합체 및 그의 이용
CN101280293B (zh) * 1998-08-06 2013-09-11 杜克大学 尿酸氧化酶
PT1588716E (pt) 1998-08-06 2011-05-25 Mountain View Pharmaceuticals Conjugados de peg-urato oxidase e sua utiliza??o
US6783965B1 (en) 2000-02-10 2004-08-31 Mountain View Pharmaceuticals, Inc. Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates

Also Published As

Publication number Publication date
HU229774B1 (en) 2014-07-28
CA2337967A1 (en) 2000-02-17
KR20010053633A (ko) 2001-06-25
CY1111001T1 (el) 2015-06-11
US7056713B1 (en) 2006-06-06
KR100841634B1 (ko) 2008-06-26
HUP0103205A2 (hu) 2001-12-28
JP2002524053A (ja) 2002-08-06
NZ509633A (en) 2003-04-29
EP1100880B1 (de) 2010-10-06
RU2290439C2 (ru) 2006-12-27
HUP0103205A3 (en) 2006-01-30
DE69942834D1 (de) 2010-11-18
ZA200100974B (en) 2002-06-26
AU766421B2 (en) 2003-10-16
HK1125402A1 (en) 2009-08-07
WO2000008196A2 (en) 2000-02-17
EP2277998B1 (de) 2016-04-20
BRPI9913360B8 (pt) 2021-05-25
AU5336599A (en) 2000-02-28
JP2013215199A (ja) 2013-10-24
CZ2001466A3 (cs) 2001-07-11
DK1100880T3 (da) 2011-01-24
HK1037214A1 (en) 2002-02-01
PT1100880E (pt) 2011-01-13
WO2000008196A3 (en) 2000-03-30
ES2352451T3 (es) 2011-02-18
WO2000008196A9 (en) 2000-07-13
PL346222A1 (en) 2002-01-28
IL141221A (en) 2010-06-16
HK1153508A1 (zh) 2012-03-30
EP1100880A4 (de) 2002-04-17
JP2010158244A (ja) 2010-07-22
CN101280293A (zh) 2008-10-08
CN1322243A (zh) 2001-11-14
JP5721954B2 (ja) 2015-05-20
IL197339A (en) 2015-02-26
EP1100880A2 (de) 2001-05-23
CA2337967C (en) 2011-11-01
EP2277998A1 (de) 2011-01-26
CZ304223B6 (cs) 2014-01-15
IL141221A0 (en) 2002-03-10
BR9913360B1 (pt) 2013-09-24
IL197339A0 (en) 2011-07-31
BR9913360A (pt) 2001-07-03
PL207369B1 (pl) 2010-12-31
CN101280293B (zh) 2013-09-11

Similar Documents

Publication Publication Date Title
ATE483797T1 (de) Harnsäureoxidase
DE69534855D1 (de) Enzymaktive dna moleküle
AU3246300A (en) Polypeptides having galactose oxidase activity and nucleic acids encoding same
WO2002014485A3 (en) Kallikrein gene
DK1117798T3 (da) Fungal transskriptionel aktivator egnet ved fremgangsmåder til produktion af polypeptider
WO2001098469A3 (en) Polypeptides having peroxidase activity and nucleic acids encoding same
WO2003016551A3 (en) Novel salicylic acid-binding protein encoding nucleic acid, sabp2, and methods of use thereof
DE502004006579D1 (de) L-carnitin dehydrogenasen, deren derivate und ein verfahren zur herstellung von substituierten (s)-alkanolen
WO2002090300A3 (en) Nucleic acids and proteins with thioredoxin reductase activity
WO2000028043A3 (en) Polypeptides having lactonohydrolase activity and nucleic acids encoding same
DE60139113D1 (de) 18477, eine menschliche proteinkinase und deren verwendung
WO2002062964A3 (en) Ap1 amine oxidase variants
AU2002306860A1 (en) Isolated human nadph oxidase, nucleic acid molecules encoding said proteins, and uses thereof
EP1383871A4 (de) Isolierte menschliche enzymproteine, menschliche enzymproteine codierende nukleinsäuremoleküle sowie verwendungen davon
WO2005003289A8 (en) Ap1 amine oxidase variants
WO2001016325A3 (en) Plant reproduction proteins
WO2003040357A3 (de) Gene die fuer phosphoenolpyruvat-zucker-phosphotransferase proteine codieren
Fu-Tai Analysis of hemoglobin variants by capillary zone electrophoresis
WO2002063013A3 (en) Human acid phosphatase gene
EP1383876A4 (de) Isolierte menschliche enzymproteine, menschliche enzymproteine codierende nukleinsäuremoleküle sowie verwendungen davon
WO2000031241A3 (en) Polypeptides having choline oxidase activity and nucleic acids encoding same
AU2002232586A1 (en) Novel s. pyogenes dna polymerase iii holoenzyme nucleic acid molecules and proteins
WO2002038765A3 (en) Dna encoding bovine immunoglobulin a inducing protein and uses therefor
EP1373294A4 (de) Isolierte menschliche enzymproteine, menschliche enzymproteine codierende nukleinsäuremoleküle und verwendungen davon
EP1383878A4 (de) Isolierte menschliche enzymproteine, menschliche enzymproteine codierende nukleinsäuremoleküle sowie verwendungen davon

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1100880

Country of ref document: EP